Find, compare & contact
Sulbactam sodium sterile (Sulbactam) API Manufacturers & Suppliers

Looking for Sulbactam API 68373-14-8?

Description:

Here you will find a list of producers, manufacturers and distributors of Sulbactam. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Sulbactam 

Synonyms:

penicillanic acid 1 , 1-dioxide , penicillanic acid sulfone , Sulbactam Benzathine , Sulbactam sodium Sterile  

Cas Number:

68373-14-8 

DrugBank number:

DB09324 

Unique Ingredient Identifier:

S4TF6I2330

Sulbactam is a type of Beta-lactamase inhibitors

Beta-lactamase inhibitors are a crucial subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that play a significant role in combating antibiotic resistance. These inhibitors are compounds specifically designed to enhance the effectiveness of beta-lactam antibiotics, which are widely used to treat bacterial infections. By inhibiting beta-lactamase enzymes, which are produced by bacteria to neutralize the activity of beta-lactam antibiotics, beta-lactamase inhibitors help restore the efficacy of these antibiotics.

The mechanism of action of beta-lactamase inhibitors involves binding to beta-lactamase enzymes, preventing them from inactivating beta-lactam antibiotics. This allows the antibiotics to effectively target and eliminate bacteria that would otherwise be resistant to their activity. By combining beta-lactamase inhibitors with beta-lactam antibiotics, healthcare professionals can overcome antibiotic resistance, expanding the range of infections that can be effectively treated.

Some commonly used beta-lactamase inhibitors include clavulanic acid, sulbactam, and tazobactam. These inhibitors are often formulated in combination with beta-lactam antibiotics, such as penicillins and cephalosporins, to create powerful therapeutic agents.

The development of beta-lactamase inhibitors is a critical strategy in the fight against antibiotic resistance, as it helps to extend the lifespan of existing antibiotics. By leveraging these inhibitors, healthcare providers can continue to use beta-lactam antibiotics effectively and combat infections caused by drug-resistant bacteria. Ongoing research and development efforts in this subcategory of pharmaceutical APIs are aimed at improving the efficacy and safety profiles of beta-lactamase inhibitors, thereby addressing the global challenge of antibiotic resistance.

Sulbactam (Beta-lactamase inhibitors), classified under Antibacterials

Antibacterials, a category of pharmaceutical active pharmaceutical ingredients (APIs), play a crucial role in combating bacterial infections. These APIs are chemical compounds that target and inhibit the growth or kill bacteria, helping to eliminate harmful bacterial pathogens from the body.

Antibacterials are essential for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and more. They are commonly prescribed by healthcare professionals to combat both mild and severe bacterial infections.

Within the category of antibacterials, there are different classes and subclasses of APIs, each with distinct mechanisms of action and target bacteria. Some commonly used antibacterials include penicillins, cephalosporins, tetracyclines, macrolides, and fluoroquinolones. These APIs work by interfering with various aspects of bacterial cellular processes, such as cell wall synthesis, protein synthesis, DNA replication, or enzyme activity.

The development and production of antibacterial APIs require stringent quality control measures to ensure their safety, efficacy, and purity. Pharmaceutical manufacturers must adhere to Good Manufacturing Practices (GMP) and follow rigorous testing protocols to guarantee the quality and consistency of these APIs.

As bacterial resistance to antibiotics continues to be a significant concern, ongoing research and development efforts aim to discover and develop new antibacterial APIs. The evolution of antibacterials plays a crucial role in combating emerging bacterial strains and ensuring effective treatment options for infectious diseases.

In summary, antibacterials are a vital category of pharmaceutical APIs used to treat bacterial infections. They are designed to inhibit or kill bacteria, and their development requires strict adherence to quality control standards. By continually advancing research in this field, scientists and pharmaceutical companies can contribute to the ongoing battle against bacterial infections.

• Sinoway industrial Co.,Ltd from China, product country of origin China
• Shandong Octagon Chemicals Limited from China, product country of origin China
• Qilu Tianhe from China, product country of origin China
• Zhejiang Hisun Pharma from China, product country of origin China
• Eumedica Pharmaceuticals from Spain, product country of origin Spain
• ACS Dobfar from Italy, product country of origin Italy
• Shin Poong Pharm from South Korea, product country of origin South Korea
• Zhuhai United Labs from China, product country of origin China
• Yuhan Chemical from South Korea, product country of origin South Korea

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.